We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Neural Interface Uses Thoughts to Controls Medical Devices

By HospiMedica International staff writers
Posted on 18 Apr 2019
Print article
Image: The Stentrode system implantable electrode array (Photo courtesy of Synchron).
Image: The Stentrode system implantable electrode array (Photo courtesy of Synchron).
New neural interface technology could restore communication in patients with severe paralysis due to debilitating diseases.

The Synchron (Campbell, CA, USA) Stentrode system is based on a platinum electrode array designed to record electrical frequencies emitted by the brain in people paralyzed due to stroke, motor neuron disease, amyotrophic lateral sclerosis (ALS), and spinal cord injury. The signals are streamed wirelessly to specialized artificial intelligence (AI) and machine learning algorithms that can interpret them and predict brain activity. Mounted on a nitinol endovascular stent, the array is small and flexible enough to be delivered via cerebral angiography, obviating open brain surgery.

Implanted via the jugular vein, the Stentrode is placed inside the brain in the motor cortex. The electrical brain discharge signals are captured and sent to a wireless antenna unit implanted in the chest, which are forwarded to an external receiver. “Thought-to-Text” technology, based on proprietary BrainOS AI modular training software, is then used to teach the patient how to control a digital human application programming interface (API) in order to operate 3rd party assistive devices. The first clinical trial of Stentrode will take place at The Royal Melbourne and Bethlehem Hospitals, both in Melbourne (Australia).

“The initiation of this trial is a milestone for the technology industry and points towards a new form of treatment for people with paralysis. There is currently no means for recovery for patients beyond the natural healing process,” said neurointerventionalist Thomas Oxley, MD, PhD, of Mount Sinai Hospital (New York, NY, USA), and CEO of Synchron. “The coupling of the Stentrode with our BrainOS technology represents a potential solution to enable people to regain control of their world, but with digital means. For people who have lost the ability to communicate, this technology could be life changing.”

Direct electrical stimulation and recording of brain activity requires invasive procedures, such as the removal of a portion of the skull or the drilling of a burr hole. Also, electrode implantation into tissue can cause inflammatory tissue responses and brain trauma, and lead to device failure.

Related Links:
Synchron

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.